Vascular Permeability in Cerebral Cavernous Malformations
- 13 May 2015
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 35 (10), 1632-1639
- https://doi.org/10.1038/jcbfm.2015.98
Abstract
Patients with the familial form of cerebral cavernous malformations (CCMs) are haploinsufficient for the CCM1, CCM2, or CCM3 gene. Loss of corresponding CCM proteins increases RhoA kinase-mediated endothelial permeability in vitro, and in mouse brains in vivo. A prospective case-controlled observational study investigated whether the brains of human subjects with familial CCM show vascular hyperpermeability by dynamic contrast-enhanced quantitative perfusion magnetic resonance imaging, in comparison with CCM cases without familial disease, and whether lesional or brain vascular permeability correlates with CCM disease activity. Permeability in white matter far (WMF) from lesions was significantly greater in familial than in sporadic cases, but was similar in CCM lesions. Permeability in WMF increased with age in sporadic patients, but not in familial cases. Patients with more aggressive familial CCM disease had greater WMF permeability compared to those with milder disease phenotype, but similar lesion permeability. Subjects receiving statin medications for routine cardiovascular indications had a trend of lower WMF, but not lesion, permeability. This is the first demonstration of brain vascular hyperpermeability in humans with an autosomal dominant disease, as predicted mechanistically. Brain permeability, more than lesion permeability, may serve as a biomarker of CCM disease activity, and help calibrate potential drug therapy.Keywords
This publication has 37 references indexed in Scilit:
- The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPasesNature Medicine, 2009
- Evidence for Statin Pleiotropy in HumansCirculation, 2009
- Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesisHuman Molecular Genetics, 2008
- Hemorrhage From Cavernous Malformations of the BrainStroke, 2008
- Dynamic contrast‐enhanced quantitative perfusion measurement of the brain using T1‐weighted MRI at 3TJournal of Magnetic Resonance Imaging, 2008
- Validation of Dynamic Contrast-Enhanced Magnetic Resonance Imaging-Derived Vascular Permeability Measurements Using Quantitative Autoradiography in the RG2 Rat Brain Tumor ModelNeoplasia, 2007
- Quantitation and localization of blood‐to‐brain influx by magnetic resonance imaging and quantitative autoradiography in a model of transient focal ischemiaMagnetic Resonance in Medicine, 2005
- Comparative Overview of Brain Perfusion Imaging TechniquesStroke, 2005
- Variations in Structural Protein Expression and Endothelial Cell Proliferation in Relation to Clinical Manifestations of Cerebral Cavernous MalformationsNeurosurgery, 2005
- A Comparison of the Clinical Profile of Cavernous Malformations with and without Associated Venous MalformationsNeurosurgery, 1999